Study of INBRX-109 in Conventional Chondrosarcoma

NCT04950075 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Conventional Chondrosarcoma

Interventions

DRUG: INBRX-109
DRUG: Placebo

Sponsor

Inhibrx Biosciences, Inc